FdaApplication
BLA 021081
Identifiers
- fda_app_no: BLA021081
Properties
| Property | Value |
|---|---|
| applicant_name | Sanofi-Aventis U.S. LLC |
| application_type | BLA |
| approval_date | 2000-04-20 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LANTUS | INSULIN GLARGINE RECOMBINANT | 1,000UNITS/10ML (100UNITS/ML) | Injection |
| LANTUS | INSULIN GLARGINE RECOMBINANT | 300UNITS/3ML (100UNITS/ML) | Injection |
| LANTUS | — | 500UNITS/5ML (100UNITS/ML) | Injection |
| LANTUS | — | 300UNITS/3ML (100UNITS/ML) | Injection |
4 products